Archive

New guidelines for managing blood cancers in pregnancy

Written by Charlie King | 5 Jan 2025

A new set of guidelines has been developed to assist with the diagnosis and expert management of serious blood cancers in pregnancy. About 12.5 pregnancies per 100,000 are… read more.

FDA investigation of blood cancer risk from Skysona (elivaldogene autotemcel) – Bluebird Bio

Written by Charlie King | 5 Dec 2024

The FDA is investigating reports of patients developing blood cancer after receiving bluebird bio’s gene therapy Skysona (elivaldogene autotemcel) and is evaluating the need for “further regulatory… read more.

Daiichi Sankyo to present new clinical research across its oncology portfolio at ESMO 2024, ASH 2024 and SABCS 2024

Written by Charlie King | 4 Dec 2024

Daiichi Sankyo will present new clinical research across its oncology portfolio with more than 45 abstracts in multiple types of solid and blood cancers at the 2024 ESMO… read more.

Kite to present extensive CAR T-Cell therapy data across blood cancers at ASH 2024 annual meeting

Written by Charlie King | 8 Nov 2024

Kite, a Gilead Company (Nasdaq: GILD), will share 18 presentations, including six oral presentations, demonstrating the strength of its CAR T-cell therapy portfolio across a spectrum of blood… read more.

Sylvester research shows new treatment may enable more patients with high-risk blood cancers to receive stem cell transplants

Written by Charlie King | 3 Jun 2024

A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to… read more.

Metformin appears to reduce the risk of blood cancer

Written by Bruce Sylvester | 23 May 2024

Patients who are treated with metformin for type 2 diabetes are less likely to develop a myeloproliferative neoplasm (MPN). Myeloproliferative neoplasms are cancers that occur when the body… read more.

New insights to enhance treatment and diagnosis of blood cancer

Written by Charlie King | 17 Sep 2023

A ground-breaking study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has revealed crucial insights into the role of the… read more.

New data informs treatment of blood cancer during pregnancy

Written by Charlie King | 6 Jun 2023

Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a progression-free survival rate of 24% and an overall survival rate of 83%…. read more.

Study reveals how chronic blood cancer transitions to aggressive disease

Written by Bruce Sylvester | 2 Jan 2023

A type of chronic leukemia can simmer for many years. Some patients may need treatment to manage this type of blood cancer — called myeloproliferative neoplasms (MPN) —… read more.

Researchers find treatment options for patients whose blood cancer relapses after CAR-T

Written by Charlie King | 9 Nov 2022

Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known… read more.

Novel treatment effective for bladder cancer, study in mice shows

Written by Charlie King | 17 Oct 2022

An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports… read more.

Leipzig hematologists research rare forms of blood cancer

Written by Charlie King | 24 Sep 2022

Why do up to 80 per cent of patients with bone marrow cancer (multiple myeloma) develop bone damage (osteolysis) in some regions of the body while others are… read more.

1 2 Next »

Archive

Subscribe for our mailing list

Follow Us